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Abstract The induction of apoptosis in Jurkat T-lymphocytes 
with 50 μΜ hydrogen peroxide was associated with caspase 
activation. Caspase activity was first detected 3 h after 
treatment, and the morphological features of apoptosis were 
apparent by 6 h. At higher concentrations of hydrogen peroxide 
there was no detectable caspase activity, and the cells died by 
necrosis. Cells treated with hydrogen peroxide were impaired in 
their ability to undergo Fas-mediated apoptosis. This appeared to 
be the result of direct inhibition of the cysteine-dependent 
caspases. The cells were able to recover and undergo apoptosis at 
later times. Therefore, hydrogen peroxide has two distinct 
effects. It initially inhibits the caspases and delays apoptosis. 
Then, depending on the degree of the initial oxidative stress, the 
caspases are activated and the cells die by apoptosis, or they 
remain inactive and necrosis occurs. We discuss the physiological 
implications of cells having to maintain a reducing environment 
during apoptosis to allow the caspases to function. 
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1. Introduction 
The caspases are a novel class of at least 10 cysteine pro-
teases that play a critical role during apoptosis. Their name 
reflects the active cysteine group, and the characteristic cleav-
age of their targets at aspartate residues [1]. Caspases are 
present in the cell cytoplasm in an inactive proform. Pro-cas-
pases become activated during apoptosis by proteolytic proc-
essing at specific sites, followed by assembly of the active 
form. The active enzyme can cleave a number of defined sub-
strates, and lead to the eventual dismantling of the cell (re-
viewed in [2,3]). One example is poly-ADP ribose polymerase, 
which is cleaved at a specific Asp-Glu-Val-Asp (DEVD) se-
quence. Caspase-3 has been identified as the caspase respon-
sible for much of this activity [4]. The ability of some caspases 
to cleave and activate the pro-caspase form of other family 
members suggests a defined cascade of proteolytic events [2,3]. 
Attempts are being made to elucidate these networks as in-
hibition of selected caspases can block many of the subse-
quent morphological and biochemical changes associated 
with apoptosis. 
Reactive oxygen species (ROS) have also been implicated as 
mediators of apoptosis. While a high degree of oxidative stress 
can cause necrosis, lower levels will trigger apoptosis [5,6]. In 
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addition, increased ROS levels have been detected emanating 
from apoptotic cells, and antioxidants can block apoptosis in 
a variety of systems (reviewed in [7,8]). The ROS hydrogen 
peroxide is generated during normal metabolism, and is also 
produced in large amounts by phagocytic cells at inflamma-
tory sites [9]. Hydrogen peroxide is known to modulate a 
variety of cell functions [10], and its lower biological reactivity 
compared to many ROS, combined with its capacity to cross 
membranes and diffuse away from the site of generation, 
makes it an ideal signalling molecule. In this study we have 
investigated the effect of hydrogen peroxide on caspase activ-
ity in Jurkat T-lymphocytes. Addition of hydrogen peroxide 
activated the caspases and led to apoptosis. However, activa-
tion occurred several hours after consumption of the hydro-
gen peroxide by the cells, and these concentrations initially 
impaired the ability of the cells to undergo Fas-mediated 
apoptosis. 
2. Materials and methods 
2.1. Materials 
Jurkat cells were obtained from the Microbiology and Tumour 
Biology Centre, Karolinska Institutet. DEVD-AMC was from Bach-
em (Bubendorf, Switzerland), and anti-Fas IgM (CH-11) was from 
Medical and Biological Laboratories (Nagoya, Japan). The Apop-
test-FITC kit was from Nexins Research B.V. (Hoeven, The Nether-
lands). All other chemicals were from Sigma (St. Louis, MO). 
2.2. Cell culture 
Cells were cultured in RPMI 1640 with 10% heat-inactivated foetal 
calf serum and 2 mM glutamine, 100 U/ml penicillin, and 100 μg/ml 
streptomycin. Cultures were incubated at 37°C in humidified air with 
5% carbon dioxide, and kept in logarithmic phase by routine passage 
every 2-3 days. Before use cells were centrifuged at 500 Xg for 5 min 
and resuspended in fresh medium at 1 X 106/ml. 
2.3. Caspase activity 
The measurement of DEVD-AMC cleavage was modified from 
Nicholson et al. [4]. Cells were pelleted and frozen on microtitre plates 
at 1X 106 cells per 25 μΐ. 50 μΐ of buffer (100 mM HEPES, 10% 
sucrose, 5 mM dithiothreitol, 10"6% ΝΡ-40, and 0.1% CHAPS at 
pH 7.25) was added to each well along with 50 μΜ of DEVD-
AMC. Substrate cleavage to release free aminomethylcoumarin 
(AMC) (excitation 355 nm, emission of 460 nm) was monitored 
with time at 37°C. Fluorescent units were converted to pmoles of 
AMC using a standard curve generated with free AMC. 
2.4. Cell blebbing and nuclear fragmentation 
The number of cells with large membrane protrusions was counted 
by light microscopy. Samples were also centrifuged at 500Xg for 
5 min and resuspended in 4% paraformaldehyde before being spread 
on slides coated with 3-aminopropyltriethoxysilane, stained with 
10 μg/ml Hoechst 33342, and sealed with Eukit and a coverslip. The 
fluorescent nuclei were viewed with a Leitz Diaplan fluorescent micro-
scope. 
2.5. Phosphatidylserine (PS) exposure 
PS exposure was measured by the binding of annexin V-FITC ac-
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cording to the protocol outlined by the manufacturers in the Apop-
test-FITC kit. Cells were also stained with 100 μκ/ηιΐ propidium io-
dide, before being analysed with a Becton Dickinson FACScan flow 
cytometer with a 15 mW 488 nm argon laser. 
2.6. Hydrogen peroxide consumption 
Hydrogen peroxide concentrations were measured using the ferrous 
oxidation of xylenol orange assay [11]. At specific intervals the cells 
were pelleted and supernatants were added to the FOX reagent. An 
increase in A560 nm was measured, and concentration was calculated 
with a standard curve generated with reagent hydrogen peroxide. 
3. Results 
Oxidants are known to induce both apoptosis and necrosis 
in cells [5,6], with the concentrations required dependent on 
the cell type being investigated. We therefore characterised the 
response of Jurkat T-lymphocytes to hydrogen peroxide. In-
duction of apoptosis was slow with hydrogen peroxide, but by 
6 h distinctive apoptotic changes were detectable. At 50 μΜ 
hydrogen peroxide flow cytometry with annexin-FITC showed 
that PS, normally constrained to the inner leaflet of the plas-
ma membrane [12], appeared on the outer surface of 25% of 
the cells (Fig. IB). Membrane blebbing and nuclear fragmen-
tation was detected in 20 ±4% and 13 ± 3 % (S.E. of n = 3) of 
the cells respectively. The exclusion of propidium iodide or 
trypan blue showed that the cells maintained their plasma 
membrane integrity at this stage (Fig. 1B,D); however, higher 
concentrations of hydrogen peroxide led to the appearance of 
necrotic cells (Fig. 1C,D). 
Caspase activity in the hydrogen peroxide-treated cells was 
measured using DEVD peptide conjugated to the fluorophore 
AMC [4]. At 50 μΜ hydrogen peroxide there was a 10-fold 
increase in the rate of DEVD-AMC cleavage compared to 
control cells. Cleavage was inhibited by addition of DEVD-
CHO to the wells, indicating that it was specific for caspases 
(not shown) [4]. Optimal caspase activation occurred at 50 
μΜ hydrogen peroxide, followed by a decline in activity at 
higher concentrations (Fig. ID). Above 200 μΜ, caspase ac-
tivity dropped below the background activity seen in control 
cells. There was a 25% decrease in the ability of the cells to 
exclude trypan blue at 500 μΜ (Fig. ID), and these necrotic 
cells could also be detected by flow cytometry (Fig. 1C). The 
dye exclusion assays are insensitive markers. Most cells 
showed gross morphological damage when viewed under the 
light microscope, yet could still exclude the dyes. At the high-
er concentrations of hydrogen peroxide, all cells eventually 
became necrotic (not shown), however there were no signs 
Fig. 1. Caspase activation and apoptosis in Jurkat cells treated with hydrogen peroxide. Jurkat cells (1 X 106/ml) were treated with varying con-
centrations of hydrogen peroxide for 6 h. After this time samples were taken and PS exposure, viability, and caspase activity were determined. 
A representative experiment of PS exposure after (A) 0 μΜ, (B) 50 μΜ, or (C) 500 μΜ hydrogen peroxide treatment is shown. (D) DEVD-
AMC cleavage (·) and trypan blue exclusion (o) were measured, and the means and S.E. of at least three experiments are shown. 
554 M.B. Hampton, S. OrreniuslFEBS Letters 414 (1997) 552-556 
pi 50-Q 
< 
Q 
> 
■50 
-40 
■30 
-20 
■10 
time (h) 
Fig. 2. Time course of caspase activation and hydrogen peroxide 
consumption. Jurkat cells (1 X 106/ ml) were treated with 0 (■) or 
50 μΜ (·) hydrogen peroxide, and samples were harvested at vari-
ous times and assayed for their ability to cleave DEVD-AMC. The 
rate of DEVD-AMC cleavage is presented as triplicate determina-
tions from one of three representative experiments. The consump-
tion of 50 μΜ hydrogen peroxide is shown (o)· In experiments 
without cells, the media alone after 30 min only consumed 15% of 
the hydrogen peroxide added. 
of apoptosis - PS exposure did not occur (Fig. 1C), and there 
was no blebbing or nuclear fragmentation. 
A time course of cells treated with 50 μΜ hydrogen per-
oxide showed a 3 h delay in caspase activation, before a rapid 
increase in activity after this time (Fig. 2). Measurement of the 
consumption of hydrogen peroxide by the cells showed that 
the majority of the hydrogen peroxide disappeared within 30 
min (Fig. 2). 
As high concentrations of hydrogen peroxide appeared to 
inhibit the caspases, and activating concentrations only did so 
hours after consumption of the initial trigger, we were inter-
ested in the ability of the cells to respond to other apoptotic 
triggers at the same time as being treated with apoptosis-in-
ducing concentrations of hydrogen peroxide. We investigated 
Fas (CD95)-mediated apoptosis, a well characterised system 
in which major apoptotic changes are detectable within 1-2 h, 
and these changes are dependent on caspase activity [13]. Low 
concentrations of hydrogen peroxide inhibited the activation 
of caspases in Jurkat cells treated with anti-Fas antibody. This 
effect was most apparent when hydrogen peroxide was added 
30-60 min after the initial trigger (Fig. 3). There was up to a 
40% inhibition of caspase activity at 50 and 100 μΜ, levels 
that go on to stimulate apoptosis. Inhibition was not due to 
impairment of the Fas signalling pathway. Extensive inhibi-
tion was seen when the peroxide was added at 90 min, which 
is just before the cells were harvested, washed, and caspase 
activity measured. This indicates a direct effect on the cas-
pases active at this time. In contrast, hydrogen peroxide had 
little or no effect on caspase activation when added 30 min 
before triggering with anti-Fas antibody (Fig. 3). If hydrogen 
peroxide was acting by disrupting signal transduction of the 
Fas receptor its effect should have been most apparent at this 
time. 
The cells appeared to recover from the early hydrogen per-
oxide treatment to have normal caspase levels. A time course 
of caspase activation following anti-Fas antibody stimulation 
confirmed this. The addition of hydrogen peroxide 30 min 
after Fas activation delayed the subsequent induction of cas-
pase activity for a further 30 min, but did not alter the net 
responsiveness obtained (Fig. 4). Membrane blebbing and nu-
clear fragmentation, which are dependent on caspase activity, 
were also delayed (not shown). The addition of hydrogen 
peroxide 30 min before the anti-Fas antibody had no detect-
able effect on the system, supporting the observation that the 
cells only required that amount of time to recover (Fig. 4). 
4. Discussion 
We have shown that hydrogen peroxide has two distinct 
effects on caspase activity in Jurkat T-lymphocytes. Firstly, 
hydrogen peroxide can activate the caspases and cause apop-
tosis. However, higher concentrations did not trigger caspase 
activity, and there was a long lag phase before caspase acti-
vation with the lower concentrations, suggesting that hydro-
gen peroxide may also have an inhibitory effect on these cys-
teine-dependent proteases. Indeed, we found that Jurkat cells 
treated with concentrations of hydrogen peroxide that even-
tually caused apoptosis were initially impaired in their ability 
to undergo Fas-mediated apoptosis. This indicates a dual reg-
ulation, with the ability of oxidative stress to trigger caspases 
and apoptosis balanced by the oxidative inhibition of caspase 
activity. While the ability of oxidants to activate apoptosis is 
well known, the potential for inhibition of this process, and 
the physiological consequences thereof, have been largely 
ignored. 
Other studies have also shown that the addition of ROS or 
redox-active compounds can induce apoptosis, and that high 
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Fig. 3. Effect of hydrogen peroxide on Fas-mediated caspase activa-
tion. Jurkat cells were stimulated with 250 ng/ml anti-Fas antibody 
and caspase activity after 90 min was measured. The effect of add-
ing hydrogen peroxide at the indicated times was determined. 
• = 50 μΜ, A = 100 μΜ, and B = 200 μΜ. The mean and S.E. of at 
least three experiments are shown. 
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Fig. 4. Effect of hydrogen peroxide on the time course of caspase 
activation in Fas-treated cells. Jurkat cells (·) were stimulated with 
250 ng/ml anti-Fas antibody, and the rate of DEVD-AMC cleavage 
was measured at various times after stimulation. ■ = addition 30 
min after anti-Fas, o = addition of 200 μΜ hydrogen peroxide 30 
min before the anti-Fas. Results are triplicate determinations from 
one of three representative experiments. 
concentrations of these agents can cause necrotic cell death 
[5,6]. We propose that the necrosis-inducing effects are due to 
the sensitivity of the caspases to oxidative inactivation. If the 
oxidative challenge is sufficiently high, the cell cannot main-
tain a reducing environment, and the caspases will not func-
tion. An orderly disassembling of the cell would not occur, 
and necrosis will ensue. In our study, the increase in hydrogen 
peroxide to levels that did not activate the caspases correlated 
with the switch from apoptotic to necrotic death. 
The most likely mechanism for the observed inhibition of 
both caspase activity and subsequent apoptosis is a direct 
effect of hydrogen peroxide on the caspases themselves. The 
active cysteine group makes all of the caspase family members 
potential targets. It would depend on the time that the hydro-
gen peroxide was added as to which caspase would be af-
fected. Receptor trimerisation and association of the factors 
that bind to the intracellular death domain of the Fas receptor 
occurs within seconds [14]. Caspase-8, the first of the caspases 
proposed to be involved in this apoptotic pathway, should be 
activated shortly after this. Caspase-3 activity can be detected 
within 20 min, and this enzyme is a major contributor to 
DEVD cleavage measured after this time, although other fam-
ily members such as caspase-7 are likely to contribute [3]. 
Addition of hydrogen peroxide directly before the cells were 
harvested, washed, and assayed confirmed that direct inacti-
vation of the caspases present at the later times could occur. 
Hydrogen peroxide had little effect when added before or at 
the same time as the anti-Fas antibody. This indicates that 
transduction of the Fas signal was not being impaired. How-
ever, the caspases present at this time should still be inacti-
vated. The reason that this inhibition was not detected 90-120 
min later is that the effect appeared to be temporary, and 
given time, the cells were able to recover normal caspase 
function. The nature of this recovery is currently unclear, 
but may involve either repair or replacement of the damaged 
proteins. As the delay and recovery in Fas-mediated apoptosis 
lasted for only 30 min, caspase inhibition by hydrogen per-
oxide is unlikely to be responsible for the 3 h delay that we 
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observed in hydrogen peroxide-mediated apoptosis. Other rate 
limiting steps in the pathway from hydrogen peroxide con-
sumption to caspase activation seem to be involved. As yet, 
little is known about this transduction pathway. 
Studies in our laboratory with the dithiocarbamate class of 
compounds support the conclusions presented here [15]. These 
compounds are commonly used as inhibitors of apoptosis or 
NFRB activation, an activity ascribed to their antioxidant 
capacity. However, it was shown that they function by inacti-
vating the caspases at critical thiol-containing residues [15]. 
Similar effects would be predicted with other physiological 
oxidants including Superoxide, nitric oxide, peroxynitrite, 
and hypochlorous acid. Indeed, Dimmeier et al. [16] have 
recently shown that caspase-1 and caspase-3 are inhibited by 
nitric oxide, and they provide evidence for nitrosylation of the 
active site thiol group. 
An early burst of ROS production has been hypothesised to 
be involved in the triggering of apoptosis in a variety of mod-
els [7,8]. One prominent source of these ROS is the mitochon-
dria [17]. Our results warn that excessive ROS production at 
an early stage in apoptosis will actually block apoptosis. A 
late stage apoptotic cell also displays signs of oxidative stress 
[7]. The stress is accentuated by the active efflux of reduced 
glutathione from the dying cell [18]. Glutathione is an impor-
tant cellular antioxidant that will help maintain the caspases 
in their active form. At these late stages ROS may be impor-
tant is downregulating caspase activity. 
Oxidative inactivation of the caspases may be important in 
various pathological states. Phagocytic cells are a major 
source of reactive oxidants in the body, and while hydrogen 
peroxide is rapidly converted to more reactive species that are 
directed at invading pathogens, levels around 100 μΜ have 
been measured during inflammation [9]. While phagocytes 
may be more resistant to these levels, bystander lymphocytes 
and endothelial cells at inflammatory sites will be affected. 
Tumour cells have also been proposed to have a higher 
'prooxidant status' [19]. Ras-transformed fibroblasts generate 
increased ROS [20], and Clement and Stamenkovic [21] re-
cently proposed that increased intracellular Superoxide levels 
were responsible for the resistance of some cell lines to Fas-
induced apoptosis. We speculate that the mechanism is due to 
oxidative inactivation of the caspases. We note that this and 
most other studies have been performed with a single bolus of 
hydrogen peroxide. Enzymatic physiological sources, while 
potentially lower, will be maintained at continuous levels for 
much longer times. This is likely to prevent cell recovery and 
enhance the inhibitory phase of apoptosis by oxidants. 
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